Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling

Nucleic Acids Research

Volumn 39, Issue 1, 2011, Pages 119-131

  Stockert, Josefine ^a   Adhikary, Till ^a   Kaddatz, Kerstin ^a   Finkernagel, Florian ^a   Meissner, Wolfgang ^a   Müller Brüsselbach, Sabine ^a   Müller, Rolf ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOPHILIN; ANGIOPOIETIN LIKE 4; CARNITINE PALMITOYLTRANSFERASE I; GENE PRODUCT; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PROGRAMMED DEATH 1 LIGAND 1; PYRUVATE DEHYDROGENASE KINASE 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; MYOFIBROBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SIGNAL TRANSDUCTION;

EID: 78651305275     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq773     Document Type: Article

References (36)

1. Feige, J.N., Gelman, L., Michalik, L., Desvergne, B. and Wahli, W. (2006) From molecular action to physiological outputs: peroxisome proliferator- activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res., 45, 120-159.
2. Desvergne, B., Michalik, L. and Wahli, W. (2006) Transcriptional regulation of metabolism. Physiol. Rev., 86, 465-514.
3. Barish, G.D., Narkar, V.A. and Evans, R.M. (2006) PPARd: a dagger in the heart of the metabolic syndrome. J. Clin. Invest., 116, 590-597.
4. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M. and Evans, R.M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell, 83, 803-812.
5. Chinetti, G., Fruchart, J.C. and Staels, B. (2000) Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res., 49, 497-505.
6. Naruhn, S., Meissner, W., Adhikary, T., Kaddatz, K., Klein, T., Watzer, B., Mü ller-Brü sselbach, S. and Mü ller, R. (2010) 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor b/d agonist. Mol. Pharmacol., 77, 171-184.
7. Chakravarthy, M.V., Lodhi, I.J., Yin, L., Malapaka, R.R., Xu, H.E., Turk, J. and Semenkovich, C.F. (2009) Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell, 138, 476-488.
8. Michalik, L. and Wahli, W. (2007) Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. Biochim. Biophys. Acta, 1771, 991-998.
9. Ricote, M. and Glass, C.K. (2007) PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta, 1771, 926-935.
10. Peters, J.M. and Gonzalez, F.J. (2009) Sorting out the functional role(s) of peroxisome proliferator-activated receptor-b/d (PPARb/d) in cell proliferation and cancer. Biochim. Biophys. Acta, 1796, 230-241.
11. Kilgore, K.S. and Billin, A.N. (2008) PPARb/d ligands as modulators of the inflammatory response. Curr. Opin. Investig. Drugs, 9, 463-469.
12. Mü ller, R., Rieck, M. and Mü ller-Brü sselbach, S. (2008) Regulation of cell proliferation and differentiation by PPARb/d. PPAR Res., 2008, 614852.
13. Peraza, M.A., Burdick, A.D., Marin, H.E., Gonzalez, F.J. and Peters, J.M. (2006) The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol. Sci., 90, 269-295.
14. Mü ller-Brü sselbach, S., Kö mhoff, M., Rieck, M., Meissner, W., Kaddatz, K., Adamkiewicz, J., Keil, B., Klose, K.J., Moll, R., Burdick, A.D. et al. (2007) Deregulation of tumor angiogenesis and blockade of tumor growth in PPARb-deficient mice. EMBO J., 26, 3686-3698.
15. Abdollahi, A., Schwager, C., Kleeff, J., Esposito, I., Domhan, S., Peschke, P., Hauser, K., Hahnfeldt, P., Hlatky, L., Debus, J. et al. (2007) Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc. Natl Acad. Sci. USA, 104, 12890-12895.
16. Mü ller, R., Kö mhoff, M., Peters, J.M. and Mü ller-Brü sselbach, S. (2008) A role for PPARb/d in tumor stroma and tumorigenesis. PPAR Res., 2008, 534294.
17. Ali, F.Y., Egan, K., FitzGerald, G.A., Desvergne, B., Wahli, W., Bishop-Bailey, D., Warner, T.D. and Mitchell, J.A. (2006) Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. Am. J. Respir. Cell. Mol. Biol., 34, 242-246.
18. Teunissen, B.E., Smeets, P.J., Willemsen, P.H., De Windt, L.J., Van der Vusse, G.J. and Van Bilsen, M. (2007) Activation of PPARd inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Cardiovasc Res., 75, 519-529.
19. Lakatos, H.F., Thatcher, T.H., Kottmann, R.M., Garcia, T.M., Phipps, R.P. and Sime, P.J. (2007) The role of PPARs in lung fibrosis. PPAR Res., 2007, 71323.
20. Massague, J. (2008) TGFb in cancer. Cell, 134, 215-230.
21. Padua, D., Zhang, X.H., Wang, Q., Nadal, C., Gerald, W.L., Gomis, R.R. and Massague, J. (2008) TGFb primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell, 133, 66-77.
22. Galaup, A., Cazes, A., Le Jan, S., Philippe, J., Connault, E., Le Coz, E., Mekid, H., Mir, L.M., Opolon, P., Corvol, P. et al. (2006) Angiopoietin-like 4 prevents metastasis through inhibitio of vascular permeability and tumor cell motility and invasiveness. Proc. Natl Acad. Sci. USA, 103, 18721-18726.
23. Desmouliere, A., Geinoz, A., Gabbiani, F. and Gabbiani, G. (1993) Transforming growth factor-b1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell. Biol., 122, 103-111.
24. Serini, G. and Gabbiana, G. (1996) Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-b isoforms: an in vivo and in vitro study. Wound Repair Regen., 4, 278-287.
25. Shi, Y., Hon, M. and Evans, R.M. (2002) The peroxisome proliferator-activated receptor d, an integrator of transcriptional repression and nuclear receptor signaling. Proc. Natl Acad. Sci. USA, 99, 2613-2618.
26. Lim, H.J., Moon, I. and Han, K. (2004) Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors a and d in uterine cells. Endocrinology, 145, 2886-2895.
27. Krogsdam, A.M., Nielsen, C.A., Neve, S., Holst, D., Helledie, T., Thomsen, B., Bendixen, C., Mandrup, S. and Kristiansen, K. (2002) Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor d-mediated transactivation. Biochem. J., 363, 157-165.
28. Semple, R.K., Meirhaeghe, A., Vidal-Puig, A.J., Schwabe, J.W., Wiggins, D., Gibbons, G.F., Gurnell, M., Chatterjee, V.K. and O'Rahilly, S. (2005) A dominant negative human peroxisome proliferator-activated receptor (PPAR) a is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms. Endocrinology, 146, 1871-1882.
29. Massague, J., Blain, S.W. and Lo, R.S. (2000) TGFb signaling in growth control, cancer, and heritable disorders. Cell, 103, 295-309.
30. Kaddatz, K., Adhikary, T., Finkernagel, F., Meissner, W., Mü ller- Brü sselbach, S. and Mü ller, R. (2010) Transcriptional profiling identifies functional interactions of TGFb and PPARb/d signaling: synergistic induction of ANGPTL4 transcription. J. Biol. Chem., July 1, 2010 [Epub ahead of print; doi:10.1074/jbc.M110.142018].
31. Boukamp, P., Petrussevska, R.T., Breitkreutz, D., Hornung, J., Markham, A. and Fusenig, N.E. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol., 106, 761-771.
32. Webber, M.M., Trakul, N., Thraves, P.S., Bello-DeOcampo, D., Chu, W.W., Storto, P.D., Huard, T.K., Rhim, J.S. and Williams, D.E. (1999) A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis, 20, 1185-1192.
33. Kovalovich, K., DeAngelis, R.A., Li, W., Furth, E.E., Ciliberto, G. and Taub, R. (2000) Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology, 31, 149-159.
34. Libermann, T.A. and Baltimore, D. (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol., 10, 2327-2334.
35. Orjalo, A.V., Bhaumik, D., Gengler, B.K., Scott, G.K. and Campisi, J. (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl Acad. Sci. USA, 106, 17031-17036.
36. Keir, M.E., Butte, M.J., Freeman, G.J. and Sharpe, A.H. (2008) PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol., 26, 677-704.